Press Release Description

Global Hematology Diagnostics market is expected to grow at a CAGR of 6.9% during 2021-26

According to MarkNtel Advisors’ research report, “Global Hematology Diagnostics Market Analysis, 2021”, the market is likely to grow at a CAGR of 6.9% during 2021-26. The market growth primarily attributes to the rising development of condition-specific treatment and booming awareness regarding personalized medicines. In addition to this, an increasing number of blood donations, rising prevalence of blood disorders, and technological advancements in hematology diagnostics are other significant factors backing the growth of the Hematology Diagnostics Market across the globe.

Key Questions Answered in the Study

  1. What are the current and future trends in the Global Hematology Diagnostics market? 
  2. How has the industry been evolving in terms of geography and services adoption?
  3. How has the competition been shaping across various countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the Global Hematology Diagnostics market?
  5. What are the customer orientation, purchase behavior, and expectations from the Global Hematology Diagnostics market service providers across various regions? 

Hospitals and Clinics Captured Significant Market Share

Based on End-Users, the market bifurcates into Hospitals & Clinics, Diagnostics Laboratories, Academic Institutes, and Commercial Service Providers. Of these, Hospitals & Clinics attained the highest share in the Global Hematology Diagnostics Market in the previous few years, owing to mounting patient footfall at hospitals & clinics requiring a tremendous amount of diagnostic devices. Moreover, the burgeoning trend of the collaboration of diagnostic centers & hospitals is another critical aspect likely to offer lucrative growth opportunities for the market. 

“Global Hematology Diagnostics Market Analysis, 2021” provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Hematology Diagnostics providers across the globe. Moreover, the report also includes the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.    

Asia-Pacific Exhibits Fastest Growth

Asia-Pacific is likely to register the fastest growth in the Global Hematology Diagnostics Market during 2021-26, mainly due to the rapidly expanding healthcare infrastructure in the region. Additionally, the availability of a large patient pool, surging demand for technologically advanced diagnosis processes, and burgeoning appetite for specialized healthcare are other critical aspects likely to contribute to the overall market growth in the region during the forecast period, reveals MarkNtel Advisors in their research report, “Global Hematology Diagnostics Market Analysis, 2021”.

As per MarkNtel Advisors, the major leading players in the Global Hematology Diagnostics Market are Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, and F. Hoffman-La-Roche Ltd.

Market Segmentation:

  1. By Product Type (Hematology Instruments, Hematology Analyzers, Fully-Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, Flow Cytometers, Others)
  2. By End User (Hospitals and Clinics, Diagnostics Laboratories, Academic Institute, Commercial Service Providers, Others)
  3. By Consumables (Reagents, Stains, Controls & Calibrations, Others)
  4. By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa)
  5. By Country (U.S, Canada, Brazil, Argentina, Mexico, Germany, France, The U.K, Spain, Italy, China, India, Japan, Australia, South Korea, Saudi Arabia, UAE, South Africa)
  6. By Competitors (Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd.)